Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia

The protein-protein interaction between menin and mixed lineage leukemia 1 (MLL1) plays a critical role in acute leukemias with translocations of the MLL1 gene or with mutations in the nucleophosmin 1 (NPM1) gene. As a step toward clinical translation of menin-MLL1 inhibitors, we report development of MI-3454, a highly potent and orally bioavailable inhibitor of the menin-MLL1 interaction. MI-3454 profoundly inhibited proliferation and induced differentiation in acute leukemia cells and primary patient samples with MLL1 translocations or NPM1 mutations. When applied as a single agent, MI-3454 induced complete remission or regression of leukemia in mouse models of MLL1-rearranged or NPM1-mutated leukemia, including patient-derived xenograft models, through downregulation of key genes involved in leukemogenesis. We also identified MEIS1 as a potential pharmacodynamic biomarker of treatment response with MI-3454 in leukemia, and demonstrated that this compound is well tolerated and did not impair normal hematopoiesis in mice. Overall, this study demonstrates, for the first time to our knowledge, profound activity of the menin-MLL1 inhibitor as a single agent in clinically relevant PDX models of leukemia. These data provide a strong rationale for clinical translation of MI-3454 or its analogs for leukemia patients with MLL1 rearrangements or NPM1 mutations.
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research

Related Links:

Publication date: Available online 24 February 2020Source: Blood Cells, Molecules, and DiseasesAuthor(s): Ming-Yue Duan, Ming Li, Hui Tian, Gen Tang, Yu-Cong Yang, Nian-Cai Peng
Source: Blood Cells, Molecules, and Diseases - Category: Hematology Source Type: research
Conclusion: CD146 was expressed significantly in children's B-ALL and associated with poor prognostic features including poor response and treatment outcomes and could be a possible poor prognostic factor in pediatric B-cell ALL. PMID: 32090132 [PubMed - in process]
Source: Journal of Immunology Research - Category: Allergy & Immunology Tags: J Immunol Res Source Type: research
Leukemia, Published online: 25 February 2020; doi:10.1038/s41375-020-0774-4Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq
Source: Leukemia - Category: Hematology Authors: Source Type: research
Leukemia, Published online: 25 February 2020; doi:10.1038/s41375-020-0778-0A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia
Source: Leukemia - Category: Hematology Authors: Source Type: research
Leukemia, Published online: 25 February 2020; doi:10.1038/s41375-020-0761-9T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid
Source: Leukemia - Category: Hematology Authors: Source Type: research
Source: Journal of Clinical Microbiology - Category: Microbiology Authors: Tags: The Brief Case Source Type: research
Source: Journal of Clinical Microbiology - Category: Microbiology Authors: Tags: The Brief Case Source Type: research
Leukemia, Published online: 24 February 2020; doi:10.1038/s41375-020-0770-8Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
Source: Leukemia - Category: Hematology Authors: Source Type: research
Leukemia, Published online: 24 February 2020; doi:10.1038/s41375-020-0764-6Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia
Source: Leukemia - Category: Hematology Authors: Source Type: research
This article is protected by copyright. All rights reserved. PMID: 32090320 [PubMed - as supplied by publisher]
Source: European Journal of Immunology - Category: Allergy & Immunology Authors: Tags: Eur J Immunol Source Type: research
More News: Acute Leukemia | Biomedical Science | Genetics | Leukemia | Men | Study